Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.58% | 35.69% | 31.50% | 19.56% | -115.06% |
| Total Depreciation and Amortization | 18.96% | 28.51% | 0.00% | 71.76% | 71.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.03% | -475.52% | -50.35% | -46.19% | 693.45% |
| Change in Net Operating Assets | -213.79% | 221.80% | 330.45% | 16,710.00% | 55.73% |
| Cash from Operations | -50.11% | -30.83% | -3.63% | 18.59% | -3.28% |
| Capital Expenditure | -123.21% | -99.67% | -591.12% | -1,106.90% | -82.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -123.21% | -99.67% | -604.29% | -1,106.90% | -82.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.33% | -45.92% | -336.59% | -39.53% | -245.45% |
| Issuance of Common Stock | -- | -10.70% | -100.00% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -142.92% | 99.81% | 100.00% | 100.00% |
| Cash from Financing | -394.74% | -13.52% | -102.33% | 52.94% | -101.16% |
| Foreign Exchange rate Adjustments | 84.76% | 47.37% | -400.00% | -400.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -57.62% | -26.60% | -238.27% | 1.97% | -283.31% |